J P Morgan Chase & Co reaffirmed their buy rating on shares of Roche Holding Ltd. (VTX:ROG) in a research note published on Friday. The firm currently has a price target on the healthcare company’s stock.

Several other analysts have also recently commented on the stock. Goldman Sachs Group, Inc. (The) set a CHF 335 target price on shares of Roche Holding and gave the stock a buy rating in a research note on Friday, May 26th. Morgan Stanley set a CHF 290 price objective on shares of Roche Holding and gave the company a buy rating in a research note on Monday, May 29th. Deutsche Bank AG set a CHF 273 price objective on shares of Roche Holding and gave the company a buy rating in a research note on Tuesday, June 6th. Societe Generale set a CHF 275 price objective on shares of Roche Holding and gave the company a neutral rating in a research note on Thursday, June 29th. Finally, Barclays PLC set a CHF 305 price objective on shares of Roche Holding and gave the company a buy rating in a research note on Tuesday, June 13th. One analyst has rated the stock with a sell rating, six have issued a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of Hold and an average price target of CHF 271.08.

Roche Holding (VTX:ROG) opened at 244.90 on Friday. Roche Holding has a 12 month low of CHK 218.30 and a 12 month high of CHK 273.00. The company has a 50-day moving average price of CHK 246.64 and a 200 day moving average price of CHK 251.31. The stock has a market capitalization of CHK 208.96 billion and a price-to-earnings ratio of 20.69.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Watch List News and is the property of of Watch List News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.watchlistnews.com/j-p-morgan-chase-co-reiterates-buy-rating-for-roche-holding-ltd-vtxrog/1464642.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.